These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 28625372)

  • 21. Are MADIT II criteria for implantable cardioverter defibrillator implantation appropriate for Chinese patients?
    Siu CW; Pong V; Ho HH; Liu S; Lau CP; Li SW; Tse HF
    J Cardiovasc Electrophysiol; 2010 Mar; 21(3):231-5. PubMed ID: 19804551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials.
    Hess PL; Al-Khatib SM; Han JY; Edwards R; Bardy GH; Bigger JT; Buxton A; Cappato R; Dorian P; Hallstrom A; Kadish AH; Kudenchuk PJ; Lee KL; Mark DB; Moss AJ; Steinman R; Inoue LY; Sanders G
    Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2):179-86. PubMed ID: 25669833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strain echocardiography improves risk prediction of ventricular arrhythmias after myocardial infarction.
    Haugaa KH; Grenne BL; Eek CH; Ersbøll M; Valeur N; Svendsen JH; Florian A; Sjøli B; Brunvand H; Køber L; Voigt JU; Desmet W; Smiseth OA; Edvardsen T
    JACC Cardiovasc Imaging; 2013 Aug; 6(8):841-50. PubMed ID: 23850251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction.
    Goldenberg I; Vyas AK; Hall WJ; Moss AJ; Wang H; He H; Zareba W; McNitt S; Andrews ML;
    J Am Coll Cardiol; 2008 Jan; 51(3):288-96. PubMed ID: 18206738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction.
    Goldenberg I; Moss AJ; McNitt S; Zareba W; Andrews ML; Hall WJ; Greenberg H; Case RB;
    Am J Cardiol; 2006 Aug; 98(4):485-90. PubMed ID: 16893702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.
    Hohnloser SH; Kuck KH; Dorian P; Roberts RS; Hampton JR; Hatala R; Fain E; Gent M; Connolly SJ;
    N Engl J Med; 2004 Dec; 351(24):2481-8. PubMed ID: 15590950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Sudden cardiac death in the youth. Is the new subcutaneous implantable cardioverter defibrillator S-ICD an alternative solution?].
    Roche NC; Stefuriac M; Dumitrescu N; Charbonnel A; Godreuil C; Bonnevie L
    Ann Cardiol Angeiol (Paris); 2015 Feb; 64(1):27-31. PubMed ID: 25281995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sudden cardiac death and implantable cardioverter-defibrillators.
    Turakhia MP
    Am Fam Physician; 2010 Dec; 82(11):1357-66. PubMed ID: 21121520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population.
    Chan PS; Stein K; Chow T; Fendrick M; Bigger JT; Vijan S
    J Am Coll Cardiol; 2006 Jul; 48(1):112-21. PubMed ID: 16814657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of implantable cardioverter-defibrillators.
    Sanders GD; Hlatky MA; Owens DK
    N Engl J Med; 2005 Oct; 353(14):1471-80. PubMed ID: 16207849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of subcutaneous implantable cardioverter-defibrillator in dialysis patients: Results from the S-ICD post-approval study.
    El-Chami MF; Burke MC; Herre JM; Shah MH; Sadhu A; Niebauer MJ; Kutalek SP; Carter N; Gold MR
    Heart Rhythm; 2020 Sep; 17(9):1566-1574. PubMed ID: 32376304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term benefit of primary prevention with an implantable cardioverter-defibrillator: an extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial II.
    Goldenberg I; Gillespie J; Moss AJ; Hall WJ; Klein H; McNitt S; Brown MW; Cygankiewicz I; Zareba W;
    Circulation; 2010 Sep; 122(13):1265-71. PubMed ID: 20837894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of long-term mortality in Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) patients with implantable cardioverter-defibrillators.
    Cygankiewicz I; Gillespie J; Zareba W; Brown MW; Goldenberg I; Klein H; McNitt S; Polonsky S; Andrews M; Dwyer EM; Hall WJ; Moss AJ;
    Heart Rhythm; 2009 Apr; 6(4):468-73. PubMed ID: 19324304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and mortality of patients with myocardial infarction and reduced left ventricular ejection fraction in a defined community: relation to the second multicenter automatic defibrillator implantation trial.
    Sharma PP; Greenlee RT; Anderson KP; Chyou PH; Osorio HJ; Smith PN; Hayes JH; Vidaillet H
    J Interv Card Electrophysiol; 2007 Sep; 19(3):157-64. PubMed ID: 17805953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of sleep-disordered breathing to predict occurrence of appropriate and inappropriate implantable-cardioverter defibrillator therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death.
    Kreuz J; Skowasch D; Horlbeck F; Atzinger C; Schrickel JW; Lorenzen H; Nickenig G; Schwab JO
    Am J Cardiol; 2013 May; 111(9):1319-23. PubMed ID: 23411108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchronization therapy.
    Solomon SD; Foster E; Bourgoun M; Shah A; Viloria E; Brown MW; Hall WJ; Pfeffer MA; Moss AJ;
    Circulation; 2010 Sep; 122(10):985-92. PubMed ID: 20733097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D.
    Kutyifa V; Bloch Thomsen PE; Huang DT; Rosero S; Tompkins C; Jons C; McNitt S; Polonsky B; Shah A; Merkely B; Solomon SD; Moss AJ; Zareba W; Klein HU
    Heart Rhythm; 2013 Dec; 10(12):1770-7. PubMed ID: 23973954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and economic implications of the Multicenter Automatic Defibrillator Implantation Trial-II.
    Al-Khatib SM; Anstrom KJ; Eisenstein EL; Peterson ED; Jollis JG; Mark DB; Li Y; O'Connor CM; Shaw LK; Califf RM
    Ann Intern Med; 2005 Apr; 142(8):593-600. PubMed ID: 15838065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
    Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
    Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimation of the requirement for implantable cardioverter defibrillators for the primary prevention of sudden cardiac death post-myocardial infarction based on UK national guidelines (2006).
    Scott PA; Gorman S; Andrews NP; Roberts PR; Kalra PR
    Europace; 2008 Apr; 10(4):453-7. PubMed ID: 18319266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.